| Megan O'hara, | |
|
5128 Wolfe Dr, Oak Lawn, IL 60453-3907 | |
| (708) 952-0730 | |
| Not Available |
| Full Name | Megan O'hara |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5128 Wolfe Dr, Oak Lawn, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063563690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146006627 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan O'hara, 5128 Wolfe Dr, Oak Lawn, IL 60453-5144 Ph: (708) 952-0730 | Megan O'hara, 5128 Wolfe Dr, Oak Lawn, IL 60453-3907 Ph: (708) 952-0730 |
News Archive
In a new study published online in spring 2021 and in the July issue of the journal Contraception, University of Chicago Medicine investigators and colleagues interviewed primary care providers in Illinois about their interest in providing medication abortion care and found that lifting FDA restrictions on mifepristone to allow pharmacy dispensing could normalize medication abortion, facilitate its use in primary care facilities, and address disparities in reproductive health access.
Children's National Medical Center has received a five-year grant from the National Institutes of Health to identify reliable early signs of prenatal brain injury caused by congenital heart disease. Catherine Limperopoulos, PhD, Director of the Advanced Pediatric Brain Imaging Research Laboratory at Children's National will lead the study.
InTouch Technologies®, Inc. (d.b.a. InTouch Health®), the world leader in Remote Presence Total Telemedicine solutions, announced today the completion of a private placement of $10 million. The financing round was led by Michigan-based Beringea through its InvestMichigan! Growth Capital Fund, which provides venture and expansion-stage capital to businesses with operations in Michigan.
Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG) vaccination as a treatment for people with existing type 1 diabetes, are actively underway.
› Verified 7 days ago
Traci Lynn Tague, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-1989 | |
Anna Manilla, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 248-701-7523 | |
Erin M Shannon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4300 W 108th Pl, Oak Lawn, IL 60453 Phone: 708-423-3078 | |
Elizabeth Maeve Nolan, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4560 W 103rd St Ste 2, Oak Lawn, IL 60453 Phone: 708-860-5015 | |
Jennifer Andrekus, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9830 Brandt Ave, Oak Lawn, IL 60453 Phone: 708-423-7820 | |
Noreen Philbin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10620 S Kolin Ave, Oak Lawn, IL 60453 Phone: 708-228-1498 | |
Emily Quinn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10201 S Cicero Ave Ste F, Oak Lawn, IL 60453 Phone: 815-469-1500 Fax: 779-216-3069 |